Home » Market News » DirectorsTalk Highlights » Developing Innovative Peptides – Investor Briefing from ImmuPharma PLC
Immupharma Plc

Developing Innovative Peptides – Investor Briefing from ImmuPharma PLC

ImmuPharma PLC is a drug discovery and development company. The Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The Company has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company’s drug candidate and is a treatment for lupus, and life threatening auto immune disease

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.